Press Releases Correvio Pharma Corp. Nasdaq

Equities

CORV

CA22026V1058

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+1.06%	+2.41%

2020	Mark Corrigan Departs as CEO from Correvio Pharma Corp	CI
2020	Justin Renz, CFO Departs from Correvio Pharma Corp	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Correvio Pharma : Obtains Final Order for Plan of Arrangement	22/20/22	PR
Correvio Pharma : Announces Results from Annual General and Special Meeting of Securityholders	16/20/16	PR
Correvio Pharma : Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA	06/20/06	PR
Correvio Pharma : Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19	04/20/04	PR
Correvio Pharma : Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA	01/20/01	PR
Correvio Pharma : Obtains Interim Order For Plan Of Arrangement	09/20/09	PR
Correvio Pharma : Reports Full Year 2019 Financial Results	30/20/30	PR
CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV	21/20/21	BU
Correvio Pharma : ADVANZ PHARMA to Acquire Correvio	16/20/16	PR
Correvio Pharma : Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities	28/20/28	PR
Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events	24/19/24	PR
Correvio Pharma : IIROC Trade Resumption - CORV	11/19/11	AQ
Correvio Pharma : IIROC Trading Halt - CORV	10/19/10	AQ
Correvio Pharma : to Present at the 2019 Cantor Global Healthcare Conference	27/19/27	PR
Correvio Pharma : to Present at the H.C. Wainwright 21st Annual Global Investment Conference	04/19/04	PR
Correvio Pharma : Closes Public Offering of 9,200,000 Common Shares	07/19/07	PR
Correvio Pharma : Announces Pricing Of Public Offering Of Common Shares	02/19/02	PR
Correvio Pharma : Announces Overnight Marketed Offering of Common Shares	02/19/02	PR
Correvio Pharma : to Report First Quarter 2019 Financial Results on May 8, 2019	01/19/01	PR
Correvio Pharma : to present at the H.C. Wainwright Global Life Sciences Conference	02/19/02	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Correvio Pharma Corp. Nasdaq

Equities

CORV

CA22026V1058

Press Releases

Filters